|
"wu ty"的相關文件
顯示項目 1-10 / 55 (共6頁)
1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-07-11 |
Effectiveness of full mRNA vaccinations to prevent COVID-19 among immunocompromised patients receiving tixagevimab-cilgavimab as pre-exposure prophylaxis-authors' response
|
Chen, PY;Wu, TY;Wang, JT;Liu, WD;Chen, YC;Chang, SC |
| 國家衛生研究院 |
2025-07-01 |
Association between wet-bulb globe temperature with gastroesophageal reflux disease in different geographic regions in a large Taiwanese population study
|
Chen, CC;Huang, HY;Wu, TY;Su, WY;Lin, TH;Tu, HP;Wu, CD;Kuo, CH;Chen, SC |
| 國家衛生研究院 |
2025-04-09 |
Effectiveness of full mRNA vaccinations to prevent COVID-19 among immunocompromised patients receiving tixagevimab-cilgavimab as pre-exposure prophylaxis
|
Chen, PY;Wu, TY;Wang, JT;Liu, WD;Chen, YC;Chang, SC |
| 國家衛生研究院 |
2024-10-07 |
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients response
|
Wu, TY;Chen, PY;Wang, JT;Liu, WD;Chen, YC;Chang, SC |
| 國家衛生研究院 |
2024-05 |
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients
|
Wu, TY;Chen, PY;Wang, JT;Liu, WD;Chen, YC;Chang, SC |
| 國家衛生研究院 |
2024-03-08 |
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
|
Wu, TY;Tsai, WT;Chen, KH;Huang, ST;Huang, CF;Kuo, PH;Tsai, MJ;Liu, WD;Lin, KY;Huang, YS;Cheng, A;Chen, PY;Sun, HY;Huang, HH;Huang, TC;Wu, SJ;Yao, M;Wang, JT;Sheng, WH;Hung, CC;Chen, YC;Chang, SC |
| 國家衛生研究院 |
2024-01-30 |
Case report: Pericardial actinomycosis in a 79-year-old man with poor dental hygiene
|
Liao, CH;Wu, TY;Lin, YL;Liu, WD;Wang, JT;Chen, JS;Ho, YL |
| 國家衛生研究院 |
2023-12-15 |
Programmable modulation of ribosomal frameshifting by mRNA targeting CRISPR-Cas12a system
|
Huang, SH;Chen, SC;Wu, TY;Chen, CY;Yu, CH |
| 國家衛生研究院 |
2023-08 |
Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma
|
Tseng, HJ;Banerjee, S;Qian, B;Lai, MJ;Wu, TY;Hsu, TI;Lin, TE;Hsu, KC;Chuang, KH;Liou, JP;Shih, JC |
| 國家衛生研究院 |
2023-06-22 |
Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and in vitro hepatic lipid homeostasis gene expression
|
Wu, TY;Tien, N;Lin, CL;Cheah, YC;Hsu, CY;Tsai, FJ;Fang, YJ;Lim, YP |
顯示項目 1-10 / 55 (共6頁)
1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
